Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Metabolomics-driven Molecular Source Analysis for personalized medicine in children

Objectif

While recent advent empowered the new reality of holistic metabolic phenotyping, we are currently still unable to accurately determine the source(s) of the underlying metabolites. This is undoubtedly the main stumbling block in inferring causality to new biomarkers for disease prevention, prediction, and prognosis, particularly given the rapidly increasing burden of metabolic diseases. At the same time, conventional metabolomics methods do not meet the requirements for adoption in clinical practice. MeMoSA will address these issues by unraveling the source hierarchy of the gastrointestinal metabolome, ultimately enabling effective personalized treatments through longitudinal source modulation and follow-up. First, two workflows for 1. high-throughput comprehensive 2D metabolomics and lipidomics and, 2. rapid clinically applicable ambient ionization metabotyping, will be developed. Second, molecular fingerprints of our unique deeply phenotyped pediatric cohorts (1.5k children) will be generated and advanced machine learning algorithms will be used to predict metabolite abundances based on their sources, i.e. diet, lifestyle, anthropometrics, microbiome, drug intake, psychological factors, clinical markers, etc. Third, a combination of in vitro digestions, in vivo humanized mice, and in silico experiments with selected source variables will be designed to contribute to our understanding of source-metabolite causality. These mechanistic insights will be used to build dedicated intervention trials in children with specific source-dominated metabotypes. MeMoSA will lay the foundation for integrating metabolomics into personalized and preventive medicine in children through (i) better prediction of individual metabotypes in relation to health; (ii) in-depth insight into metabolite sources, which will foster a framework for biomarker qualification and unraveling disease etiology; (iii) greater treatment efficacy through dedicated metabolome-driven source modulation.

Champ scientifique (EuroSciVoc)

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-ERC - HORIZON ERC Grants

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) ERC-2023-COG

Voir tous les projets financés au titre de cet appel

Institution d’accueil

UNIVERSITEIT GENT
Contribution nette de l'UE
€ 1 999 763,00
Adresse
SINT PIETERSNIEUWSTRAAT 25
9000 Gent
Belgique
Région
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
€ 1 999 763,00

Bénéficiaires (1)